FDA Adds 24 Entries to List of Drugs That Cannot Be Used in Compounding

Drug GMP Report
The FDA is revising the list of drug products that have been banned or removed from the market for safety or effectiveness reasons and so cannot be used in compounding.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00